Concepedia

Publication | Closed Access

Immunotherapy of Advanced Breast Cancer With a Heterophilic Ganglioside (NeuGcGM3) Cancer Vaccine

DOI

96

Citations

23

References

2003

Year

Adriana Carr, Edmundo Rodríguez, María del Carmen Arango, Rolando Camacho, Marta Osorio, Mariano R. Gabri, Guido Carrillo, Zolidina Valdés, Yanín Bebelagua, Rolando Pérez,
Journal of Clinical Oncology

Abstract

NeuGcGM3/VSSP/Montanide ISA 51 is an unusual immunogenic ganglioside vaccine and also seems to be safe in this small trial. Immunologic surrogates of activity indicate that this reagent warrants further investigation.

References

YearCitations

Page 1